RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Musiliyu Musa to Monoamine Oxidase Inhibitors

Back to Details
This is a "connection" page, showing publications Musiliyu Musa has written about Monoamine Oxidase Inhibitors.
Musiliyu Musa
Connection Strength
1.104
Monoamine Oxidase Inhibitors
  1. Musa MA, Badisa VLD, Aghimien MO, Eyunni SVK, Latinwo LM. Identification of 7,8-dihydroxy-3-phenylcoumarin as a reversible monoamine oxidase enzyme inhibitor. J Biochem Mol Toxicol. 2021 Feb; 35(2):e22651.
    View in: PubMed
    Score: 0.657
  2. Kolawole Q, Badisa VLD, Musa MA, Latinwo L. Coumarin-based Oximes Exert Monoamine Oxidase Inhibitory Activity. Anticancer Res. 2026 Feb; 46(2):601-610.
    View in: PubMed
    Score: 0.237
  3. Aghimien MO, Kolawole Q, Igbinoba PO, Musa MA, Latinwo L. Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine Oxidase (HMAO) Enzymes. Anticancer Res. 2024 Jun; 44(6):2335-2341.
    View in: PubMed
    Score: 0.211
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support